Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.6596
-0.0134 (-1.99%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $28.69 million as of September 11, 2026. Its market cap has decreased by -26.28% in one year.
Market Cap
28.69M
Enterprise Value
28.54M
1-Year Change
-26.28%
Ranking
Category
Stock Price
$0.66
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $28.69M, an increase of 1,514.04%. That is a compound annual growth rate of 104.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 28.69M | -51.30% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 33.68M |
| Context Therapeutics | 33.13M |
| Aligos Therapeutics | 33.10M |
| NextCure | 32.73M |
| Kyntra Bio | 32.43M |
| BeyondSpring | 32.07M |
| BriaCell Therapeutics | 31.42M |
| IGC Pharma | 29.57M |